These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8487463

  • 1. [Ocular complications of long-term survival of bone marrow transplantation. A prospective study with 21 patients].
    Bautista Juanes JA, Theischen M, Beelen DW, Pauleikhoff D, Koch JM, Waubke TN, Wessing A.
    Klin Monbl Augenheilkd; 1993 Feb; 202(2):110-5. PubMed ID: 8487463
    [Abstract] [Full Text] [Related]

  • 2. Current status of bone marrow transplantation in humans: report from the International Bone Marrow Transplant Registry.
    Bortin MM, Horowitz MM, Gale RP.
    Nat Immun Cell Growth Regul; 1988 Feb; 7(5-6):334-50. PubMed ID: 3065641
    [Abstract] [Full Text] [Related]

  • 3. Ocular manifestations of graft versus host disease following bone marrow transplantation.
    Claes K, Kestelyn P.
    Bull Soc Belge Ophtalmol; 2000 Feb; (277):21-6. PubMed ID: 11126670
    [Abstract] [Full Text] [Related]

  • 4. [Ophthalmologic findings in graft versus host disease (GvHD)].
    Käsmann B, Ruprecht KW.
    Klin Monbl Augenheilkd; 1993 Jun; 202(6):491-9. PubMed ID: 8397319
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow transplantation. The state of the art.
    Thomas ED.
    Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
    [No Abstract] [Full Text] [Related]

  • 6. Dry eye syndrome in long-term follow-up of bone marrow transplanted patients.
    Calissendorff B, el Azazi M, Lönnqvist B.
    Bone Marrow Transplant; 1989 Nov; 4(6):675-8. PubMed ID: 2819286
    [Abstract] [Full Text] [Related]

  • 7. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
    Huang H, Lin M, Meng H.
    Zhonghua Yi Xue Za Zhi; 2001 Mar 10; 81(5):263-7. PubMed ID: 11798883
    [Abstract] [Full Text] [Related]

  • 8. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
    Tichelli A, Duell T, Weiss M, Socié G, Ljungman P, Cohen A, van Lint M, Gratwohl A, Kolb HJ.
    Bone Marrow Transplant; 1996 Jun 10; 17(6):1105-11. PubMed ID: 8807122
    [Abstract] [Full Text] [Related]

  • 9. Importance of bone marrow cell dose in bone marrow transplantation.
    Paulin T.
    Clin Transplant; 1992 Feb 10; 6(1):48-54. PubMed ID: 10150090
    [Abstract] [Full Text] [Related]

  • 10. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
    Kusminsky G, Foncuberta MC, Aversa L, Drelichman G, Freigeiro D, Burgos R, Irrazabal C, Gonzalez G, Dictar M, Niborski R, Kohan A, Sanchez Avalos JC.
    Medicina (B Aires); 2000 Feb 10; 60(2):179-87. PubMed ID: 10962806
    [Abstract] [Full Text] [Related]

  • 11. Late pulmonary impairment following allogeneic bone marrow transplantation.
    Beinert T, Düll T, Wolf K, Holler E, Vogelmeier C, Behr J, Kolb H.
    Eur J Med Res; 1996 Apr 18; 1(7):343-8. PubMed ID: 9364037
    [Abstract] [Full Text] [Related]

  • 12. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q, Dong M, Wang QM, Wen JY, Wu XY.
    Ai Zheng; 2006 Oct 18; 25(10):1261-5. PubMed ID: 17059772
    [Abstract] [Full Text] [Related]

  • 13. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T, Kojima S, Kato K.
    Bone Marrow Transplant; 1998 Jul 18; 22(1):21-6. PubMed ID: 9678791
    [Abstract] [Full Text] [Related]

  • 14. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J, Wu B, Liu Q, Feng R, Liu X, Meng F, Zhou S.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug 18; 21(8):400-2. PubMed ID: 11877009
    [Abstract] [Full Text] [Related]

  • 15. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
    Godder KT, Henslee-Downey PJ, Mehta J, Park BS, Chiang KY, Abhyankar S, Lamb LS.
    Bone Marrow Transplant; 2007 Jun 18; 39(12):751-7. PubMed ID: 17450185
    [Abstract] [Full Text] [Related]

  • 16. Late ocular complications after bone marrow transplantation.
    Tichelli A.
    Nouv Rev Fr Hematol (1978); 1994 Jun 18; 36 Suppl 1():S79-82. PubMed ID: 8177722
    [Abstract] [Full Text] [Related]

  • 17. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K, Tabayashi T, Yamada K, Takeuchi M.
    Bone Marrow Transplant; 2002 Jan 18; 29(1):63-6. PubMed ID: 11840146
    [Abstract] [Full Text] [Related]

  • 18. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.
    Bone Marrow Transplant; 1996 May 18; 17(5):685-9. PubMed ID: 8733682
    [Abstract] [Full Text] [Related]

  • 19. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S, Ringdén O, Aschan J, Hägglund H, Ljungman P, Mattsson J, Remberger M.
    Clin Transplant; 1998 Apr 18; 12(2):84-92. PubMed ID: 9575394
    [Abstract] [Full Text] [Related]

  • 20. Ocular complications of pediatric bone marrow transplantation.
    Ng JS, Lam DS, Li CK, Chik KW, Cheng GP, Yuen PM, Tso MO.
    Ophthalmology; 1999 Jan 18; 106(1):160-4. PubMed ID: 9917798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.